Key clinical point: The quality of apps for seronegative spondyloarthritis was overall low, with apps originating in the United Kingdom and Canada achieving higher scores.
Major finding: The overall Mobile App Rating Score was 3.8/5.0 for 23 provider- and patient-directed spondyloarthritis apps.
Study details: Review of 23 mobile apps for Android and iOS focused on spondyloarthritis.
Disclosures: The authors reported no conflicts of interest and no outside sources of funding.
Iyer P et al. SPARTAN 2019.